Mesenchymal stem cell therapy in type 2 diabetes mellitus

Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic strategies. Transplantation of insulin-producing cells (IPCs) was once thought to be the most promising strategy for treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Li, Hao, Haojie, Liu, Jiejie, Li, Yijun, Han, Weidong, Mu, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433043/
https://www.ncbi.nlm.nih.gov/pubmed/28515792
http://dx.doi.org/10.1186/s13098-017-0233-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433043/
https://www.ncbi.nlm.nih.gov/pubmed/28515792
http://dx.doi.org/10.1186/s13098-017-0233-1

Ejemplares similares